Changing The Pharma Playing Field In Japan

15 September 1996

On a dreary, hot and humid day during the last week of August, TV cameras rolled outside the Japanese Ministry of Health and Welfare (Koseisho) while 90 people from the prosecutor's office entered the building to remove files related to the approval of blood products during the mid-1980s. Unbelievably, and for the first time in history, a government ministry was raided.

Radical Reform Of The Approval System Two days earlier, the Koseisho announced a sweeping reorganization of its Pharmaceutical Affairs Bureau (Marketletters September 2 and 9), effectively disbanding its functions of drug approval, safety of drugs and promotion of the pharmaceutical industry.

The AIDS scandal precipitated this long overdue restructuring of the Koseisho's functions. However, in retrospect this was inevitable.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight